Back Derivatives Strategy

Weakness From the Magnificent 7 Makes Owning Index Hedges More Attractive as Market Navigates thru Tariff Headlines

Published on February 9, 2025

∙ Download the PDF Report

By

Jeff Jacobson

The relative weakness we have seen from the “Mag 7” names since mid-December could be a signal that the main indexes (SPY and QQQ) could be in danger of more than just a slight pullback from their all-time highs. With six of the seven names already having reported earnings, all but META are lower since they reported and in many cases a lot lower (TSLA – 7%, GOOGL -10.4%, MSFT – 7.4%). In most cases the stocks dropped initially on earnings, and we have seen little to no lift since.

I created an equal-weighted Mag7 index, and that shows that since peaking on both an absolute, and relative to the index, basis in December they have declined by ~ 6.5% (vs a 0.25% decline for the SPX (SPY) and 2.25% drop for the NDX (QQQ). While the main SPX index has been able to hold up incredibly well in the face of the Mag7 weakness, should the market get further concerning news on tariffs, and/or inflation, the indices could be susceptible for a much larger decline than we have seen thus far given the overall weakness from the top-weighted names. In addition, should these names remain under pressure that likely puts a “cap” to the index upside in the shorter-term given their importance. Just to reiterate how important these seven stocks are to both the NDX and SPX, they comprise a total weighting of 43% in the NDX and a 32% weighting in the SPX.

The Mag7 names peaked in mid-December and have been significantly underperforming both SPY and QQQ since

Looking at just the Mag7 equal-weighted index alone we see that after peaking in December and making a lower-high on the January market bounce, it is now below both the September uptrend and the 50-day support. While we have seen other cases like this recently of declines (most notably the July drop), I can’t recall a recent time where most (all but one) of the names are signaling relative underperformance to the overall market. If we recall, it was these very names that supported the bid to the indices while most other areas of the market were under pressure for the better part of the last year. This action in the Mag7 is occurring with the major indices still just below their all-time highs and implied volatility still relatively low. In addition, the added risks/unknown we have on the tariff front, that seem unlikely to be resolved anytime soon, means owning index hedges here with a heavy Mag7 weighting remains a favorable option in my opinion. We have already seen the market react negatively a few times on just the mention of tariffs with some of our main trading partners.

I created an equal-weighted Mag7 index. After peaking in December it made a lower high on the market rebound in January and is now below the Sept uptrend and 50-day support

When deciding what expiration to own for market hedges now, I would lean towards owning March structures over the shorter-dated February ones. While there is still the unknown on the tariff front, we do know that the 1-month extension given to both Mexico and Canada will need to be addressed again in early March. In addition, there are two other known events that March hedges will capture that February will not. The first is Nvidia (NVDA) earnings on Feb 26th, and the second is the FOMC rate decision on March 19th. Given the Deepseek news and reaction by may of the tech/AI names, all eyes will be on NVDA when they report and discuss the possible impact on future sales/guidance. As far as the March FOMC meeting, we always see a bid to volatility as we approach the meeting which further supports owning vol now that captures the event. While I continue to advocate owning vol/hedges, I do think put spreads are starting to look a bit more attractive than owning puts outright. First, realized volatility has come in somewhat. Second, we have seen put skew move up in both SPY and QQQ and given the longer-duration March expiry I think wider put spreads make more sense. Given the high weighting of the Mag7 names in both SPY and QQQ, I think either make sense as a portfolio hedge.

Here are two specific put spread hedges I want to highlight:

Trade #1

Buy SPY March 590/540 put spread for ~ $5.35 (SPY 600.77 ref)

  • Put spread starts 1.5% below spot (after factoring in the ex-dividend on 3/21)
  • Structure offers a whopping 8.3x to 1 max payoff with the 50-point wide put spread being capped down at the September lows
  • Selling the 540 puts as part of the put spread hedge covers a full 20% of the cost of buying the much higher delta 590 puts (selling 22.36 vol/buying 14.95 vol)
  • Spending less than 1% of the underlying to own the 6-week hedge that protects against a 10% decline
  • March expiry captures 2 CPI prints, another payroll report, NVDA earnings on 2/26 and then next FOMC decision on 3/19

SPY March hedge has a wide range of profitability and nearly 6-weeks of duration

Trade #2

Buy QQQ March 510/460 put spread for $6.15 (QQQ 522.92 ref)

  • Buying the March protective put spread that starts 2.5% below spot
  • Put spread offers an attractive 7x to 1 max payout and is capped just above the September lows
  • 43% weighting of the Mag7 names in QQQ and they continue to act poorly
  • Selling the 460 put covers ~ 19% of the cost of buying the higher-delta 510 put (selling 27.6 vol/buying 20.2 vol)
  • March expiry captures 2 CPI prints, another payroll report, NVDA earnings on 2/26 and then next FOMC decision on 3/19

QQQ March hedge also offers a wide range for profitability and six weeks of duration

DISCLOSURES AND DISCLAIMERS

Analyst Certification

The analyst, 22V Research Group, primarily responsible for the preparation of this research report attests to the following: (1) that the views and opinions rendered in this research report reflect his or her personal views about the subject companies or issuers; and (2) that no part of the research analyst’s compensation was, is, or will be directly related to the specific recommendations or views in this research report.

Analyst Certifications and Independence of Research.

Each of the 22V Research analysts whose names appear on the front page of this report hereby certify that all the views expressed in this Report accurately reflect our personal views about any and all of the subject securities or issuers and that no part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views of in this Report.

22V Research (the “Company”) is an independent research provider. The Company is not a member of the FINRA or the SIPC and is not a registered broker dealer or investment adviser. 22V Research has no other regulated or unregulated business activities which conflict with its provision of independent research.

22V Research, LLC is a professional services and independent publication organization. 22V Research, LLC is not a securities broker-dealer, not a member of the Financial Industry Regulatory Authority (FINRA), not a registered investment advisor (RIA) and not a member of SIPC.

Securities transactions, when offered, are offered by 22V Securities, LLC through LPS Capital, LLC. Certain employees of 22V Securities, LLC are dually registered as securities representatives of LPS Capital, LLC or Analyst Hub Securities, LLC. 22V Securities, LPS Capital and Analyst Hub Securities are members FINRA, SIPC.

https://brokercheck.finra.org/

Current Ratings Definition.

SECTOR OUTPERFORM: An “outperform” rating anticipates the company will outperform the S&P Regional Banking Index (peer group).

SECTOR PERFORM: A “market perform” rating anticipates the company will perform in line with the S&P Regional Banking Index (peer group).

SECTOR UNDERPERFORM: An “underperform” rating anticipates the company will underperform the S&P Regional Banking Index (peer group).

Limitation Of Research And Information.

This Report has been prepared for distribution to only qualified institutional or professional clients of 22V Research Group. The contents of this Report represent the views, opinions, and analyses of its authors. The information contained herein does not constitute financial, legal, tax or any other advice. All third-party data presented herein were obtained from publicly available sources which are believed to be reliable; however, the Company makes no warranty, express or implied, concerning the accuracy or completeness of such information. In no event shall the Company be responsible or liable for the correctness of, or update to, any such material or for any damage or lost opportunities resulting from use of this data. Nothing contained in this Report or any distribution by the Company should be construed as any offer to sell, or any solicitation of an offer to buy, any security or investment. Any research or other material received should not be construed as individualized investment advice. Investment decisions should be made as part of an overall portfolio strategy and you should consult with a professional financial advisor, legal and tax advisor prior to making any investment decision. 22V Research Group shall not be liable for any direct or indirect, incidental or consequential loss or damage (including loss of profits, revenue or goodwill) arising from any investment decisions based on information or research obtained from 22V Research Group.

Reproduction And Distribution Strictly Prohibited.

No user of this Report may reproduce, modify, copy, distribute, sell, resell, transmit, transfer, license, assign or publish the Report itself or any information contained therein. Notwithstanding the foregoing, clients with access to working models are permitted to alter or modify the information contained therein, provided that it is solely for such client’s own use. This Report is not intended to be available or distributed for any purpose that would be deemed unlawful or otherwise prohibited by any local, state, national or international laws or regulations or would otherwise subject the Company to registration or regulation of any kind within such jurisdiction.

Copyrights, Trademarks, Intellectual Property.

22V Research Group, and any logos or marks included in this Report are proprietary materials. The use of such terms and logos and marks without the express written consent of 22V Research Group is strictly prohibited. The copyright in the pages or in the screens of the Report, and in the information and material therein, is proprietary material owned by 22V Research Group unless otherwise indicated. The unauthorized use of any material on this Report may violate numerous statutes, regulations and laws, including, but not limited to, copyright, trademark, trade secret or patent laws.